Dr Reddys Laboratories (RDY) Cash from Investing Activities (2009 - 2026)

Dr Reddys Laboratories has reported Cash from Investing Activities for 17 years, with the latest figure at $40.5 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 118.07% year-over-year to $40.5 million in Q2 2026; TTM through Jun 2026 was -$520.9 million, a 37.35% increase from a year earlier, with the FY2026 full-year figure at -$700.0 million, down 2.64% from the prior year.
• Cash from Investing Activities was $40.5 million for Q2 2026 at Dr Reddys Laboratories, up from -$109.4 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $71.9 million in Q3 2022, with the low at -$321.7 million in Q4 2022.
• Average Cash from Investing Activities over 5 years is -$146.2 million, with a median of -$164.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities sank 772.92% in 2022, then soared 118.07% in 2026.
• Over 5 years, Cash from Investing Activities stood at -$321.7 million in 2022, then soared by 39.59% to -$194.3 million in 2023, then decreased by 17.18% to -$227.7 million in 2024, then soared by 51.94% to -$109.4 million in 2025, then soared by 137.03% to $40.5 million in 2026.
• The last three Cash from Investing Activities figures came in at $40.5 million (Q2 2026), -$109.4 million (Q3 2025), and -$224.3 million (Q2 2025), per Business Quant data.